Osteolab
ActiveSummary
Osteolab has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €140,616 and a net result of €100,116. Equity is growing by ~26.8% per year across the filed fiscal years. Its solvency ranks better than 26% of 16765 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability97▲+4
Solvency56▼-1
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €10,000 at 30 days acceptable
Liquidity tight (current ratio 1.07 against 0.92 in 2024; short-term debt: 34.2% and cash: 1.5% of total assets), and 68.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
31.4%
Return on assets
22.3%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-05-2026, 66 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
66 d early
2024
9 d early
2023
26 d early
2022
7 d early
2021
13 d early
2020
4 d early
2019
41 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 12 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 18 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€140,616▲ 0.1%
2024 · €140,500
Total assets
€447,979▲ 3.1%
2024 · €434,492
Net result
€100,116▲ 19.5%
2024 · €83,802
Working capital
€11,261
2024 · -€9,383
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€79,643▲ 70.4%€77,864▼ 2.2%€98,220▲ 26.1%€110,196▲ 12.2%€128,149▲ 16.3%
Net result€55,871within the sector's middle half▲ 57.3%€54,562within the sector's middle half▼ 2.3%€73,232within the sector's middle half▲ 34.2%€83,802within the sector's middle half▲ 14.4%€100,116within the sector's middle half▲ 19.5%
Equity€68,904within the sector's middle half▲ 1.3%€83,466within the sector's middle half▲ 21.1%€116,698within the sector's middle half▲ 39.8%€140,500within the sector's middle half▲ 20.4%€140,616within the sector's middle half▲ 0.1%
Total assets€476,188within the sector's middle half▼ 3.1%€420,080within the sector's middle half▼ 11.8%€422,404within the sector's middle half▲ 0.6%€434,492within the sector's middle half▲ 2.9%€447,979within the sector's middle half▲ 3.1%
Debt€407,284▼ 3.8%€336,614▼ 17.4%€305,706▼ 9.2%€293,992▼ 3.8%€307,363▲ 4.5%
Working capital-€66,011below the sector's middle half▲ 4.2%-€56,321below the sector's middle half▲ 14.7%-€44,782below the sector's middle half▲ 20.5%-€9,383below the sector's middle half▲ 79.0%€11,261within the sector's middle half
Solvency14.5%below the sector's middle half▲ 0.6pp19.9%below the sector's middle half▲ 5.4pp27.6%below the sector's middle half▲ 7.8pp32.3%below the sector's middle half▲ 4.7pp31.4%within the sector's middle half▼ 0.9pp
Current ratio0.46below the sector's middle half▲ 0.160.38below the sector's middle half▼ 0.080.56below the sector's middle half▲ 0.180.92below the sector's middle half▲ 0.361.07below the sector's middle half▲ 0.15
Return on assets (ROA)11.7%within the sector's middle half▲ 4.5pp13.0%within the sector's middle half▲ 1.3pp17.3%within the sector's middle half▲ 4.3pp19.3%within the sector's middle half▲ 2.0pp22.3%within the sector's middle half▲ 3.1pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 16% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €447,979
Fixed assets
€283,376 ▼ 12.6%
Current assets
€164,603 ▲ 49.0%
Equity and liabilities €447,979
Equity
€140,616 ▲ 0.1%
Debt
€307,363 ▲ 4.5%
Debt's share of the balance-sheet total rises from 67.7% to 68.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€173,986▲
2024 · €156,567
Cash flow
€145,953▲
2024 · €130,173
Debt to equity
2.19▲
2024 · 2.09
ROE
71.2%▲
2024 · 59.6%
Interest coverage
40.52▲
2024 · 32.62
Debt ≤ 1 year
€153,342▲
2024 · €119,819
Debt > 1 year
€145,729▼
2024 · €171,659
Income taxes
€30,315▲
2024 · €24,550
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.6%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €49,497 | €42,845 | €47,221 | €46,371 | €45,837 | ▼ 1.2% |
| Other operating charges640/8 | €2,655 | €2,683 | €4,107 | €3,080 | €2,880 | ▼ 6.5% |
| Non-recurring operating charges66A | - | - | - | - | €661 | - |
| Gross operating margin9900 | €131,795 | €123,392 | €149,549 | €159,647 | €177,527 | ▲ 11.2% |
| Operating profit (loss)9901 | €79,643 | €77,864 | €98,220 | €110,196 | €128,149 | ▲ 16.3% |
| Financial income75/76B | €491 | €37 | €420 | €2,955 | €6,575 | ▲ 122% |
| Recurring financial income75 | €491 | €37 | €420 | €2,955 | €6,575 | ▲ 122% |
| Financial charges65/66B | €7,437 | €6,416 | €5,144 | €4,800 | €4,294 | ▼ 10.5% |
| Recurring financial charges65 | €7,437 | €6,416 | €5,144 | €4,800 | €4,294 | ▼ 10.5% |
| Profit (loss) for the period before taxes9903 | €72,696 | €71,485 | €93,496 | €108,352 | €130,430 | ▲ 20.4% |
| Income taxes67/77 | €16,826 | €16,924 | €20,264 | €24,550 | €30,315 | ▲ 23.5% |
| Profit (loss) for the period9904 | €55,871 | €54,562 | €73,232 | €83,802 | €100,116 | ▲ 19.5% |
| Profit (loss) for the period to be appropriated9905 | €55,871 | €54,562 | €73,232 | €83,802 | €100,116 | ▲ 19.5% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €476,188 | €420,080 | €422,404 | €434,492 | €447,979 | ▲ 3.1% |
| Fixed assets21/28 | €419,932 | €385,073 | €365,769 | €324,056 | €283,376 | ▼ 12.6% |
| Intangible fixed assets21 | €120,493 | €100,493 | €80,493 | €60,493 | €40,493 | ▼ 33.1% |
| Tangible fixed assets22/27 | €299,439 | €284,580 | €285,276 | €263,563 | €242,883 | ▼ 7.8% |
| Land and buildings22 | €283,341 | €270,262 | €253,035 | €236,814 | €219,535 | ▼ 7.3% |
| Plant, machinery and equipment23 | €10,166 | €10,141 | €21,993 | €21,542 | €18,285 | ▼ 15.1% |
| Furniture and vehicles24 | €5,932 | €4,177 | €10,247 | €5,207 | €5,063 | ▼ 2.8% |
| Current assets29/58 | €56,256 | €35,007 | €56,635 | €110,436 | €164,603 | ▲ 49.0% |
| Amounts receivable within one year40/41 | €43,066 | €18,273 | €41,359 | €106,234 | €157,044 | ▲ 47.8% |
| Trade receivables40 | €9,513 | €6,150 | €1,188 | €1,207 | €1,150 | ▼ 4.7% |
| Other amounts receivable41 | €33,553 | €12,123 | €40,171 | €105,027 | €155,894 | ▲ 48.4% |
| Cash at bank and in hand54/58 | €12,342 | €15,523 | €13,768 | €3,538 | €6,503 | ▲ 83.8% |
| Deferred charges and accrued income490/1 | €848 | €1,211 | €1,508 | €664 | €1,056 | ▲ 59.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €476,188 | €420,080 | €422,404 | €434,492 | €447,979 | ▲ 3.1% |
| Equity10/15 | €68,904 | €83,466 | €116,698 | €140,500 | €140,616 | ▲ 0.1% |
| Contributions10/11 | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €50,304 | €64,866 | €98,098 | €121,900 | €122,016 | ▲ 0.1% |
| Non-distributable reserves130/1 | €682 | €682 | €0 | - | - | - |
| Reserves not available under the articles1311 | €682 | €682 | €0 | - | - | - |
| Distributable reserves133 | €49,623 | €64,184 | €98,098 | €121,900 | €122,016 | ▲ 0.1% |
| Profit (loss) carried forward14 | - | - | €0 | €0 | €0 | - |
| Amounts payable17/49 | €407,284 | €336,614 | €305,706 | €293,992 | €307,363 | ▲ 4.5% |
| Amounts payable after more than one year17 | €284,367 | €244,636 | €204,289 | €171,659 | €145,729 | ▼ 15.1% |
| Financial debts170/4 | €284,367 | €244,636 | €204,289 | €171,659 | €145,729 | ▼ 15.1% |
| Amounts payable within one year42/48 | €122,266 | €91,328 | €101,417 | €119,819 | €153,342 | ▲ 28.0% |
| Current portion of amounts payable after more than one year42 | €39,113 | €39,731 | €40,348 | €34,543 | €25,930 | ▼ 24.9% |
| Financial debts43 | €22,015 | - | €10,292 | €17,796 | €19,660 | ▲ 10.5% |
| Credit institutions430/8 | €22,015 | - | €10,292 | €17,796 | €19,660 | ▲ 10.5% |
| Trade debts44 | €3,273 | €6,523 | €3,090 | €4,716 | €7,437 | ▲ 57.7% |
| Suppliers440/4 | €3,273 | €6,523 | €3,090 | €4,716 | €7,437 | ▲ 57.7% |
| Taxes, remuneration and social security45 | €2,865 | €5,074 | €7,688 | €2,764 | €315 | ▼ 88.6% |
| Taxes450/3 | €2,865 | €5,074 | €7,688 | €2,764 | €315 | ▼ 88.6% |
| Other amounts payable47/48 | €55,000 | €40,000 | €40,000 | €60,000 | €100,000 | ▲ 66.7% |
| Accrued charges and deferred income492/3 | €650 | €650 | €0 | €2,514 | €8,292 | ▲ 230% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €55,871 | €54,562 | €73,232 | €83,802 | €100,116 | ▲ 19.5% |
| + Depreciation and write-downs630 | €49,497 | €42,845 | €47,221 | €46,371 | €45,837 | ▼ 1.2% |
| Operating cash flow (approximation) | €105,368 | €97,407 | €120,454 | €130,173 | €145,953 | ▲ 12.1% |
| Investment in fixed assets (approximation) | - | -€7,986 | -€27,917 | -€4,658 | -€5,157 | ▼ 10.7% |
| Change in cash | - | €3,181 | -€1,755 | -€10,230 | €2,965 | ▲ 129% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
26-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2018net €100,116 ▲19.5%
Operating result €128,149, net result €100,116, both a record.
22-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
05-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €100,000Eq €116,698 ▲39.8%
6 profitable years in a row build equity to €116,698.
24-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
18-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
27-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
10-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 41 days late
2019
31-12
Financial
Weakest financial yearnet €280 ▼97.9%
Net result drops to €280, the lowest in the series; recovery starts the following year.
15-06
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zwevegem · 1 establishment unit since 2018
Ground area
352 m²
Building footprint
138 m²
Volume, LiDAR
937 m³
Parcel 34042B0418/00A006, Flanders · tallest building 12.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Osteolab
since 20182.272.260.236
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34042B0418/00A006 | Flanders | 352 m² | 1 · 137 m² | 12.5 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
KH Med
BE 1009.744.066
Liège · Eq €140,647
Dr. Laura Leysen, Oftalmoloog
BE 1000.759.391
Mol · Eq €140,566
DR. E. CALLENS
BE 0830.229.730
Sint-Pieters-Leeuw · Eq €140,562
Dr. Pieter-Jan Geerts
BE 0737.458.831
Kortrijk · Eq €140,671
DILMED
BE 1006.892.167
Etterbeek · Eq €140,414
Of 16,627 companies in sector 86220 we hold annual accounts for 7,988. 6,696 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded11-01-2018
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID
0208:0687836007
Also
9925:BE0687836007
Registered
12-02-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.